Breaking News: MRNA – Market Insights, Analysis & Latest Updates

Warner Bros, Moderna, Under Armour and Lyft rise premarket

US stock futures rise post-Trump's victory, with notable premarket movers including Under Armour, Lyft, and Moderna, which reported better-than-expected earnings and forecasts.

investing.com • 07/11/2024 - 12:51 PM

MRNA

Moderna shares surge after vaccine maker posts unexpected third-quarter profit

Moderna reported unexpected net income in Q3, amidst leadership changes and declining COVID-19 vaccine sales, with revenue at $1.86 billion and a net profit of $13 million.

investing.com • 07/11/2024 - 11:59 AM

Moderna reports surprise profit on higher-than-expected COVID vaccine sales

Moderna reports a surprise Q3 profit driven by cost cuts and strong COVID vaccine sales but faces challenges with lower RSV vaccine revenue and competition.

investing.com • 07/11/2024 - 11:33 AM

Morning Bid: Fed and BOE decide as US House awaited, Germany jarred

Global markets reacted positively to Trump's election, with rising stocks and bond yields, anticipation of central bank rate cuts, and political uncertainties affecting forecasts.

investing.com • 07/11/2024 - 11:09 AM

Stock market today: S&P 500 clinches another record after Fed cuts rates again

The S&P 500 reached record highs following a Fed rate cut. Moderna and Warner Bros reported surprises, while Lyft saw a significant stock surge.

investing.com • 07/11/2024 - 00:03 AM

MRNA

Moderna CEO Bancel steps down as sales chief, Bloomberg News reports

Moderna's CEO Stephane Bancel will step down as chief commercial officer while Stephen Hoge takes charge of sales and research affairs.

investing.com • 05/11/2024 - 17:26 PM

US election looms large; earnings, Fed decision this week - what's moving markets

US stock futures show mixed activity before a busy week of events, including the presidential election, corporate earnings, and a Federal Reserve interest rate decision.

investing.com • 04/11/2024 - 08:34 AM

Saudi wealth fund to cut overseas investments

Saudi Arabia's sovereign wealth fund plans to reduce overseas investments to focus on domestic projects, aiming for economic diversification away from oil amidst regional tensions and influential economic discussions.

investing.com • 29/10/2024 - 15:09 PM

MRNA
ROVI

Spanish drugmaker Rovi to keep third-party manufacturing business

Rovi, a Spanish drugmaker, will retain its CDMO business, focusing on its strategic plan, causing shares to drop 6.1% after announcing it received five non-binding offers.

investing.com • 24/10/2024 - 08:59 AM

Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer have declined significantly due to narrowed eligibility, impacting demand and sales expectations for both companies.

investing.com • 08/10/2024 - 10:54 AM

Currency